Clinical predictors of fidelis lead failure: Report from the canadian heart rhythm society device committee

Circulation

Volumn 125, Issue 10, 2012, Pages 1217-1225

  Birnie, David H ^a   Parkash, Ratika ^b   Exner, Derek V ^c   Essebag, Vidal ^d   Healey, Jeffrey S ^e   Verma, Atul ^f   Coutu, Benoit ^g   Kus, Teresa ^h   Mangat, Iqwal ⁱ   Ayala Paredes, Felix ^j   Nery, Pablo ^a   Wells, George ^a   Krahn, Andrew D ^k  

^a UNIVERSITY OF OTTAWA   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^c LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

^f SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

^g CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^h HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

ⁱ ST MICHAEL'S HOSPITAL   (Canada)

^j UNIVERSITÉ DE SHERBROOKE   (Canada)

^k LONDON HEALTH SCIENCES CENTRE   (Canada)

more..

Author keywords

Advisory; Failure rate; Implantable cardioverter defibrillator; Lead failure; Predictors

Indexed keywords

ADULT; ARTICLE; AXILLARY VEIN; DEFIBRILLATOR; DEFIBRILLATOR FAILURE; FEMALE; FOLLOW UP; GENERATOR; HEART RHYTHM; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; SUBCLAVIAN VEIN; TIME;

AGED; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CANADA; CARDIOMYOPATHY, HYPERTROPHIC; DATABASES, FACTUAL; DEFIBRILLATORS, IMPLANTABLE; ELECTRODES, IMPLANTED; FEMALE; HEART DEFECTS, CONGENITAL; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTHESIS FAILURE; SEX DISTRIBUTION; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FIBRILLATION;

EID: 84858445307     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.053744     Document Type: Article

References (30)

1. Urgent Medical Device Information: Sprint Fidelis Lead Patient Management Recommendations. http://www.medtronic.com/productadvisories/physician/sprint- fidelis/PROD-ADV-PHYS-OCT. Accessed July 11, 2011.
2. Hauser RG, Kallinen LM, Almquist AK, Gornick CC, Katsiyiannis WT. Early failure of a small-diameter high-voltage implantable cardioverterdefibrillator lead. Heart Rhythm. 2007;4:892-896. (Pubitemid 46959208)
3. Farwell D, Green MS, Lemery R, Gollob MH, Birnie DH. Accelerating risk of Fidelis lead fracture. Heart Rhythm. 2008;5:1375-1379.
4. Faulknier BA, Traub DM, Aktas MK, Aguila A, Rosero S, Daubert JP, Hall B, Shah A, Taylor S, McNitt S, Moss AJ, Zareba W, Huang DT. Time-dependent risk of Fidelis lead failure. Am J Cardiol. 2010;105:95-99.
5. Hauser RG, Hayes DL. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure. Heart Rhythm. 2009;6:605-610.
6. Sprint Fidelis Performance Report. http://www.medtronic.com/ productadvisories/physician/sprint-fidelis/6949-LEAD-PERFORMANCE. Accessed May 31, 2011.
7. Arias MA, Dominguez-Perez L, Toquero J, Jimenez-Candil J, Olague J, Diaz-Infante E, Tercedor L, Valverde I, Castro J, Garcia-Fernandez FJ, Rodriguez-Padial L. [Sprint fidelis defibrillation lead: a nine-center experience in Spain]. Rev Esp Cardiol. 2011;64:312-318.
8. Hauser RG, Maisel WH, Friedman PA, Kallinen LM, Mugglin AS, Kumar K, Hodge DO, Morrison TB, Hayes DL. Longevity of Sprint Fidelis implantable cardioverter-defibrillator leads and risk factors for failure: implications for patient management. Circulation. 2011;123:358-363.
9. Morrison TB, Rea RF, Hodge DO, Crusan D, Koestler C, Asirvatham SJ, Bradley D, Shen WK, Munger TM, Hammill SC, Friedman PA. Risk factors for implantable defibrillator lead fracture in a recalled and a nonrecalled lead. J Cardiovasc Electrophysiol. 2010;21:671-677.
10. Ha AC, Vezi BZ, Keren A, Alanazi H, Gollob MH, Green MS, Lemery R, Nery PB, Posan E, Birnie DH. Predictors of fracture risk of a small caliber implantable cardioverter defibrillator lead. Pacing Clin Electrophysiol. 2010;33:437-443.
11. Parkash R, Crystal E, Bashir J, Simpson C, Birnie D, Sterns L, Exner D, Thibault B, Connors S, Healey JS, Champagne J, Cameron D, Mangat I, Verma A, Wolfe K, Essebag V, Kus T, Ayala-Paredes F, Davies T, Sanatani S, Gow R, Coutu B, Sivakumaran S, Stephenson E, Krahn A. Complications associated with revision of Sprint Fidelis leads: report from the Canadian Heart Rhythm Society Device Advisory Committee. Circulation. 2010;121:2384-2387.
12. Krahn AD, Champagne J, Healey JS, Cameron D, Simpson CS, Thibault B, Mangat I, Tung S, Sterns L, Birnie DH, Exner DV, Parkash R, Sivakumaran S, Davies T, Coutu B, Crystal E, Wolfe K, Verma A, Stephenson EA, Sanatani S, Gow R, Connors S, Paredes FA, Essebag V. Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee. Heart Rhythm. 2008;5:639-642.
13. Krahn AD, Simpson CS, Parkash R, Yee R, Champagne J, Healey JS, Cameron D, Thibault B, Mangat I, Tung S, Sterns L, Birnie DH, Exner DV, Sivakumaran S, Davies T, Coutu B, Crystal E, Wolfe K, Verma A, Stephenson EA, Sanatani S, Gow R, Connors S, Paredes FA, Turabian M, Kus T, Essebag V, Gardner M. Formation of a national network for rapid response to device and lead advisories: the Canadian Heart Rhythm Society Device Advisory Committee. Can J Cardiol. 2009;25:403-405.
14. Krahn AD, Simpson CS, Parkash R, Yee R, Champagne J, Healey JS, Cameron D, Thibault B, Mangat I, Tung S, Sterns L, Birnie DH, Exner DV, Sivakumaran S, Davies T, Coutu B, Crystal E, Wolfe K, Verma A, Stephenson EA, Sanatani S, Gow R, Connors S, Paredes FA, Turabian M, Kus T, Gardner M, Essebag V. Utilization of a national network for rapid response to the Medtronic Fidelis lead advisory: the Canadian Heart Rhythm Society Device Advisory Committee. Heart Rhythm. 2009;6:474-477.
15. Cheng A, Wang Y, Curtis JP, Varosy PD. Acute lead dislodgements and in-hospital mortality in patients enrolled in the National Cardiovascular Data Registry implantable cardioverter defibrillator registry. J Am Coll Cardiol. 2010;56:1651-1656.
16. Lee DS, Krahn AD, Healey JS, Birnie D, Crystal E, Dorian P, Simpson CS, Khaykin Y, Cameron D, Janmohamed A, Yee R, Austin PC, Chen Z, Hardy J, Tu JV. Evaluation of early complications related to de novo cardioverter defibrillator implantation: insights from the Ontario ICD database. J Am Coll Cardiol. 2010;55:774-782.
17. Olgun H, Karagoz T, Celiker A, Ceviz N. Patient-and lead-related factors affecting lead fracture in children with transvenous permanent pacemaker. Europace. 2008;10:844-847. (Pubitemid 351882062)
18. Parsonnet V, Roelke M. The cephalic vein cutdown versus subclavian puncture for pacemaker/ICD lead implantation. Pacing Clin Electrophysiol. 1999;22:695-697. (Pubitemid 29244981)
19. Magney JE, Staplin DH, Flynn DM, Hunter DW. A new approach to percutaneous subclavian venipuncture to avoid lead fracture or central venous catheter occlusion. Pacing Clin Electrophysiol. 1993;16:2133-2142. (Pubitemid 23322569)
20. Belott PH. Blind axillar venous access. Pacing Clin Electrophysiol. 1999;22:1085-1089.
21. Eckstein J, Koller MT, Zabel M, Kalusche D, Schaer BA, Osswald S, Sticherling C. Necessity for surgical revision of defibrillator leads implanted long-term: causes and management. Circulation. 2008;117:2727-2733. (Pubitemid 351770453)
22. Bonney WJ, Spotnitz HM, Liberman L, Silver ES, Ceresnak SR, Hordof AJ, Pass RH. Survival of transvenous ICD leads in young patients. Pacing Clin Electrophysiol. 2010;33:186-191.
23. Erkapic D, Duray GZ, Bauernfeind T, Rosa SD, Hohnloser SH. Insulation Defects of Thin High-Voltage ICD Leads: An Underestimated Problem? J Cardiovasc Electrophysiol. 2011;22:1018-1022.
24. Swerdlow CD, Gunderson BD, Ousdigian KT, Abeyratne A, Stadler RW, Gillberg JM, Patel AS, Ellenbogen KA. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter- defibrillator leads. Circulation. 2008;118:2122-2129.
25. Keren A, Sears SF, Nery P, Shaw J, Green MS, Lemery R, Gollob MH, Amyotte B, Birnie DH. Psychological adjustment in ICD patients living with advisory Fidelis leads. J Cardiovasc Electrophysiol. 2011;22:57-63.
26. Kallinen LM, Hauser RG, Tang C, Melby DP, Almquist AK, Katsiyiannis WT, Gornick CC. Lead integrity alert algorithm decreases inappropriate shocks in patients who have Sprint Fidelis pace-sense conductor fractures. Heart Rhythm. 2010;7:1048-1055.
27. Blanck Z, Axtell K, Brodhagen K, O'Hearn L, Albelo T, Ceretto C, Dhala A, Sra J, Akhtar M. Inappropriate shocks in patients with Fidelis lead fractures: impact of remote monitoring and the lead integrity algorithm. J Cardiovasc Electrophysiol. 2011;22:1107-1114.
28. Sprint Fidelis Model 6949 Lead Performance. http://www.medtronic.com/ product-advisories/physician/sprint-fidelis/PHYSLETTER-2009-03-13. Accessed July 11, 2011.
29. Maytin M, Love CJ, Fischer A, Carrillo RG, Garisto JD, Bongiorni MG, Segreti L, John RM, Michaud GF, Albert CM, Epstein LM. Multicenter experience with extraction of the Sprint Fidelis implantable cardioverterdefibrillator lead. J Am Coll Cardiol. 2010;56:646-650.
30. Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Carrillo RG, Crossley GH, III, Epstein LM, Friedman RA, Kennergren CE, Mitkowski P, Schaerf RH, Wazni OM. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management. This document was endorsed by the American Heart Association (AHA). Heart Rhythm. 2009;6:1085-1104.